Integrated Biomarkers
Psychometrics, PET, and Cortical Biomarkers
Longitudinal, multimodal modeling of secondary datasets (e.g., OASIS-3) integrating amyloid PET, structural MRI, and psychometrics to quantify continuous dementia severity and trajectories across distributed cortical and subcortical systems.
- •Psychometrics and Aβ-PET jointly stratify clinical dementia severity (AAN 2023; Neurology 100(17_supplement_2):0104).
- •Open-source, multicenter-validated stroke lesion segmentation model supports voxel-based lesion–symptom mapping (Diagnostics 12:2055, 2022).
Care Pathways
Express Dementia Care & Rural Health Equity
Closed-loop Express Dementia Care (EDCC) pathway focused on workflow design, caregiver navigation, and system-level measurement of access and readiness for disease-modifying therapies in rural East Texas.
- •EDCC operational pilot evaluates triage loops, time-to-diagnosis, and caregiver outcomes (AAN 2026 abstracts, submitted).
- •Equity analyses quantify infusion-readiness gaps and care barriers for anti-amyloid therapies.
Systems & AI
Systems Neuroscience, AI & Decision Support
Combining primate systems neuroscience with clinically grounded AI, spanning lesion–symptom mapping, physician-scored benchmarks (ExpertMedQA), and BooksMed decision support.
- •International consortium of 21 physicians across 7 countries validated ExpertMedQA / BooksMed (AAN 2024; Neurology 102(7_supplement_1):3830).
- •Inverse-graphics and optogenetic systems neuroscience studies (PNAS 2025; eLife 2022) inform algorithm design for clinical AI.